TuHURA Biosciences, Inc. (HURA)
2.05
-0.08
(-3.76%)
USD |
NASDAQ |
Sep 23, 16:00
2.05
0.00 (0.00%)
Pre-Market: 08:25
TuHURA Biosciences Price to Book Value : 7.164 for Sept. 23, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 23, 2026 | 7.164 |
| September 22, 2026 | 7.444 |
| September 21, 2026 | 7.619 |
| September 18, 2026 | 7.339 |
| September 17, 2026 | 7.304 |
| September 16, 2026 | 7.094 |
| September 15, 2026 | 7.094 |
| September 14, 2026 | 7.164 |
| September 11, 2026 | 7.164 |
| September 10, 2026 | 7.094 |
| September 09, 2026 | 7.024 |
| September 08, 2026 | 7.409 |
| September 04, 2026 | 7.479 |
| September 03, 2026 | 7.339 |
| September 02, 2026 | 7.304 |
| September 01, 2026 | 7.094 |
| August 31, 2026 | 7.444 |
| August 28, 2026 | 7.374 |
| August 27, 2026 | 7.444 |
| August 26, 2026 | 7.444 |
| August 25, 2026 | 7.129 |
| August 24, 2026 | 7.514 |
| August 21, 2026 | 6.990 |
| August 20, 2026 | 7.758 |
| August 19, 2026 | 7.968 |
| Date | Value |
|---|---|
| August 18, 2026 | 7.549 |
| August 17, 2026 | 7.968 |
| August 14, 2026 | 8.632 |
| August 13, 2026 | 8.038 |
| August 12, 2026 | 8.178 |
| August 11, 2026 | 8.038 |
| August 10, 2026 | 7.514 |
| August 07, 2026 | 7.444 |
| August 06, 2026 | 7.392 |
| August 05, 2026 | 7.304 |
| August 04, 2026 | 7.304 |
| August 03, 2026 | 7.479 |
| July 31, 2026 | 7.584 |
| July 30, 2026 | 7.584 |
| July 29, 2026 | 7.129 |
| July 28, 2026 | 7.444 |
| July 27, 2026 | 7.724 |
| July 24, 2026 | 7.374 |
| July 23, 2026 | 7.514 |
| July 22, 2026 | 7.828 |
| July 21, 2026 | 7.724 |
| July 20, 2026 | 7.828 |
| July 17, 2026 | 7.863 |
| July 16, 2026 | 7.758 |
| July 15, 2026 | 7.968 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.350 |
| Alnylam Pharmaceuticals, Inc. | 24.35 |
| Anika Therapeutics, Inc. | 1.986 |
| Savara, Inc. | 7.149 |
| Vericel Corp. | 5.364 |
Price to Book Value Related Metrics
| Price | 2.05 |
| Earnings Yield | -26.01% |
| Market Cap | 130.55M |